Skip to main content
Premium Trial:

Request an Annual Quote

A Twist on the "If You Can't Beat Them" Axiom

Larry Moran has a post at Sandwalk commenting on Michael Behe's recent reaction to a Nature paper from noted evolutionary biologist Richard Lenski. "Of the many scientists who are trying to understand evolution, Richard Lenski stands out for his experimental approach," Moran writes. "He has maintained stocks of E. coli growing under stressful conditions for over 40,000 generations."

What surprised Moran most was Behe's reaction, which was not (as some might expect) to discredit the paper, but rather to hijack its findings as support of intelligent design. "Lenski’s decades-long work lines up wonderfully with what an ID person would expect," Behe writes. "For his work in this area we should be very grateful. It gives us solid results to point to, rather than having to debate speculative scenarios."

That outcome has Moran virtually speechless. "I don't think I need to comment on such stupidity," he concludes.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.